Policy and Research

Here you will find information out about Ovacome's involvement  in leading change for those affected by ovarian cancer; now and for future generations.

PICCOS

The PICCOS trial looks at the use of pressurised intraperitioneal aerosolised chemotherapy (PIPAC) in recurrent platinum-resistant ovarian cancer. Ovacome has sat on the  Patient Advisory Group for the last two years.

Menopause guidelines update

Ovacome's Head of Support represented your perspectives on menopause.

Read about the impact this had.

Can your shopping receipt predict ovarian cancer?

Find out how data from our shopping habits can indicate undiagnosed health issues.

Patient voices change guidance for GCT monitoring

Find out how patient-led research contributed to new findings and changes to Granulosa Cell Tumour monitoring.

The GRACEFUL study

This study looks into the most important aspects of location of care for patients with gynaecological cancers.

Read more and find out how to particpate.

All-Part Parliamentary Group on Women’s Health position paper (APPG)

Ovacome is pleased to have contributed to the APPG on Women’s Health position paper on ovarian cancer, amplifying your voices and calling for change.

Become part of the Ovacome community

Our members are at the heart of everything we do. There’s no cost to membership. Be the first to hear about Ovacome news and join a friendly, supportive community, all working together to promote knowledge and support others.